CandlesenseCandlesense
IPA•benzinga•

ImmunoPrecise Antibodies Q3 2025 GAAP EPS C$(0.66) May Not Be Comparable To C$(0.08) Estimate, Sales C$6.15M Miss C$6.58M Estimate

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on March 28, 2025 by benzinga

← Back to IPA News
    ImmunoPrecise Antibodies Q3 2025 GAAP EPS C$(0.66) May Not Be Comparable To C$(0.08) Estimate, Sales C$6.15M Miss C$6.58M Estimate | IPA Stock News | Candlesense